Scientists have produced the strongest experimental evidence yet that a specific molecule made by gut bacteria, in response to a high-fat Western diet, actively speeds colorectal tumor growth rather than simply appearing alongside it. The work, from the Technical University of Munich, RWTH Aachen University, and the German Institute of Human Nutrition Potsdam-Rehbrücke, appears in the journal Gut.
The finding lands in the middle of an unsettled question that affects many households. Colorectal cancer is rising in adults under 50, and diet is the risk factor people most want a clear answer about. This research does not deliver a diet prescription. What it does is fill in the biological chain of events connecting fatty food to tumor growth, which has been missing for decades.
The immediate practical meaning is modest but real. It strengthens the case that dietary fat and fiber intake influence colorectal cancer risk through the gut microbiome, and it points toward a future in which the relevant bacteria or their products could be measured or targeted. It does not mean a single fatty meal causes cancer, and it does not change any current screening or dietary guidelines.
The Chain of Events the Researchers Traced
Fat in food triggers the liver to make primary bile acids, which the body needs to break down and absorb fats. Most are reabsorbed. A small fraction reaches the colon, where certain bacteria capable of a chemical process called 7-alpha-dehydroxylation convert them into secondary bile acids, including deoxycholic acid, or DCA.
Higher fat intake means more DCA in the colon. Elevated DCA has been repeatedly observed in people with colorectal cancer, but observation alone could never distinguish cause from consequence.
The team closed that gap by controlling the variable directly. According to reporting on the study, the researchers first fed a Western-style diet to pigs carrying a mutation in the APC gene that predisposes them to colon polyps. Tumor development worsened, DCA levels rose, and the cells lining the colon divided faster. Treating some of the pigs with cholestyramine, a drug that binds bile acids so the body can excrete them, reduced that excess cell division.
The team then turned to gnotobiotic mice, animals whose gut microbial community is fully defined. Adding DCA-producing bacteria, including Clostridium scindens and Extibacter muris, raised DCA levels and increased colon tumor counts in two mouse models. In a further experiment, researchers genetically altered another bacterium, Faecalicatena contorta, so it could no longer perform the reaction that makes DCA. Mice colonized with the altered strain developed fewer tumors than mice carrying the unmodified, DCA-producing version, and the altered strain also drove less cell proliferation in laboratory-grown human colon organoids.
Faster cell division increases the opportunities for DNA errors to accumulate, a recognized step toward cancer.
What the Human Data Adds and Where It Stops
Alongside the animal work, the team analyzed microbial DNA from stool samples across several human cohorts, covering 1,034 people with colorectal cancer and 1,108 without. Genes involved in DCA production, particularly those associated with Clostridium scindens and closely related bacteria, were found more often in people with the disease.
That human component is observational. It shows an association and cannot prove that bacterial DCA production caused cancer in any of those individuals. The causal demonstration exists in pigs and mice, and results in animal models do not automatically transfer to people.
Microbiologist Soeren Ocvirk of the German Institute of Human Nutrition said in a press announcement that the results show how much a Western high-fat diet and the accompanying microbiome changes "can affect human gut health."
The study also does not show that cholestyramine prevents or treats colorectal cancer in people. Clinical trials would be needed before bile acid-binding drugs, microbiome tests, or treatments aimed at specific bacterial pathways could be used for prevention. That caveat belongs near the top of any honest account of this study, not buried at the end.
There is still a hopeful reading. If a specific bacterial process drives part of the risk, that process can in principle be interrupted, whether by shifting the diet that feeds it, by targeting the bacteria directly, or by blocking the effect of DCA on intestinal cells.
Why Younger Adults Are Watching This Closely
Colorectal cancer is now the leading cause of cancer death among Americans under 50, and it is the only one of the top five cancers in that age group whose death rate is still rising. Overall cancer mortality below 50 fell by 44 percent between 1990 and 2023. MedicalDaily has covered why early-onset colorectal cancer is rising and the role family history plays in screening decisions.
Diet is one of several proposed explanations, alongside obesity, sedentary behavior, antibiotic exposure and early-life bacterial toxins. None has been established as the driver. This study makes the dietary microbiome pathway more plausible without settling the question.
The people with the most reason to pay attention are those with a first-degree relative diagnosed with colorectal cancer, anyone with inflammatory bowel disease, and adults who have not yet started screening. Average-risk screening in the United States begins at 45. Family history usually means starting earlier, and that conversation is worth having with a clinician rather than a search engine.
Symptoms that warrant prompt medical attention regardless of age include rectal bleeding, blood in the stool, persistent changes in bowel habits, unexplained weight loss, ongoing abdominal pain, and unexplained iron deficiency anemia. These have many benign explanations, but in younger adults, they are frequently attributed to hemorrhoids or stress and evaluated late. The American Cancer Society reported that three in four colorectal cancers in adults under 50 are found at an advanced stage.
Nothing in this research supports cutting fat drastically, buying a microbiome test or taking a supplement to alter bile acids. Broad dietary patterns higher in fiber and lower in processed and red meat are already recommended for colorectal health, and that guidance has not changed. Anyone considering a significant dietary change, especially while managing another condition, should work it through with a clinician or registered dietitian.
Key Questions Answered
What did the study actually prove? In pigs and mice, bacteria that produce deoxycholic acid caused faster colorectal tumor growth than a bacterial strain engineered not to produce it. That is causal evidence in animals.
Does this prove that fatty food causes colon cancer in people? No. The human portion of the research was observational and shows only an association. The causal experiments were done in animal models.
What is deoxycholic acid? A secondary bile acid. The liver makes primary bile acids to digest fat, and certain gut bacteria convert a fraction of them into DCA in the colon. Higher fat intake raises colonic DCA.
Should anyone change their diet based on this? Not because of this study alone. Existing advice favoring more fiber and less processed and red meat has not changed. Individual dietary decisions should be made with a clinician or dietitian.
Are microbiome tests or supplements useful here? There is no validated consumer test for DCA-producing bacteria and no approved treatment targeting this pathway. Commercial gut tests do not measure colorectal cancer risk.
Who should get screened earlier than 45? People with a first-degree relative who had colorectal cancer, those with inflammatory bowel disease, and people with certain inherited syndromes. A clinician sets the timing.
Which symptoms should not be ignored? Rectal bleeding, blood in the stool, persistent bowel habit changes, unexplained weight loss, ongoing abdominal pain, and unexplained anemia deserve evaluation at any age.
